Mutagenesis Advance Access originally published online on February 6, 2007
Mutagenesis 2007 22(2):91-103; doi:10.1093/mutage/gel068
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Epigenetics and cancer: towards an evaluation of the impact of environmental and dietary factors
Epigenetics Team, Molecular Carcinogenesis and Biomarkers Group, International Agency for Research on Cancer, 150 Cours Albert Thomas, F-69008, Lyon, France
While the field of cancer genetics has enjoyed a great deal of attention among cancer researchers in the last few decades, the appreciation of cancer epigenetics is more recent, -owing to the fact that epigenetic mechanisms have emerged as key mechanisms in cancer development. All critical changes in cancer cells, such as silencing of tumour-suppressor genes, activation of oncogenes and defects in DNA repair, are caused not only by genetic but also by epigenetic mechanisms. Epigenetic events can affect many steps in tumour development; therefore, better understanding of epigenetic mechanisms is fundamental to our ability to successfully prevent, diagnose and treat cancer. Various environmental and dietary agents and lifestyles are suspected to be implicated in the development of a wide range of human cancers by eliciting epigenetic changes, though the contribution of epigenetic mechanisms to a given human cancer type and the precise targets of epigenetic alterations during cancer development are largely unknown. The major obstacle in establishing a relationship between epigenetic changes and exposure to dietary, lifestyle and environmental factors and cancer is the fact that studies are typically too small and lack statistical power to identify the interactions between epigenetic changes and exposures. Tremendous advances in our understanding of basic epigenetic mechanisms and rapid progress that is being made in developing new powerful technologies, such as those for sensitive and quantitative detection of epigenetic changes as well as for genome-wide analysis (epigenomics), hold great promise that these issues may be addressed in near future. Therefore, experimental evidence on the precise role of epigenetic changes induced by environment, diet and lifestyle is eagerly awaited.
* To whom correspondence should be addressed. Tel: +33 4 72 73 83 98; Fax: +33 4 72 73 83 29; Email: herceg{at}iarc.fr
Received on October 16, 2006; revised on November 28, 2006; accepted on December 13, 2006.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Brait, J. G. Ford, S. Papaiahgari, M. A. Garza, J. I. Lee, M. Loyo, L. Maldonado, S. Begum, L. McCaffrey, M. Howerton, et al. Association between Lifestyle Factors and CpG Island Methylation in a Cancer-Free Population Cancer Epidemiol. Biomarkers Prev., November 1, 2009; 18(11): 2984 - 2991. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Foley, J. M. Craig, R. Morley, C. J. Olsson, T. Dwyer, K. Smith, and R. Saffery Prospects for Epigenetic Epidemiology Am. J. Epidemiol., February 15, 2009; 169(4): 389 - 400. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Vaissiere, R. J. Hung, D. Zaridze, A. Moukeria, C. Cuenin, V. Fasolo, G. Ferro, A. Paliwal, P. Hainaut, P. Brennan, et al. Quantitative Analysis of DNA Methylation Profiles in Lung Cancer Identifies Aberrant DNA Methylation of Specific Genes and Its Association with Gender and Cancer Risk Factors Cancer Res., January 1, 2009; 69(1): 243 - 252. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Fleming, T. H-M. Huang, and A. E. Toland The Role of Parental and Grandparental Epigenetic Alterations in Familial Cancer Risk Cancer Res., November 15, 2008; 68(22): 9116 - 9121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Wolff, G. Liang, C. C. Cortez, Y. C. Tsai, J. E. Castelao, V. K. Cortessis, D. D. Tsao-Wei, S. Groshen, and P. A. Jones RUNX3 Methylation Reveals that Bladder Tumors Are Older in Patients with a History of Smoking Cancer Res., August 1, 2008; 68(15): 6208 - 6214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Ji, L. Yang, L. Yu, J. Yuan, D. Hu, W. Zhang, J. Yang, Y. Pang, W. Li, J. Lu, et al. Epigenetic silencing of O6-methylguanine DNA methyltransferase gene in NiS-transformed cells Carcinogenesis, June 1, 2008; 29(6): 1267 - 1275. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Sadikovic, J. Andrews, D. Carter, J. Robinson, and D. I. Rodenhiser Genome-wide H3K9 Histone Acetylation Profiles Are Altered in Benzopyrene-treated MCF7 Breast Cancer Cells J. Biol. Chem., February 15, 2008; 283(7): 4051 - 4060. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. L. Martin Epigenomics and disease, 10th anniversary winter meeting of the UK Molecular Epidemiology Group (MEG), The Royal Statistical Society, London, UK, 8th December 2006 Mutagenesis, November 1, 2007; 22(6): 425 - 427. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Conti, M. L. Castellani, D. Kempuraj, V. Salini, J. Vecchiet, S. Tete, F. Mastrangelo, A. Perrella, M. A. De Lutiis, M. Tagen, et al. Role of Mast Cells in Tumor Growth Ann. Clin. Lab. Sci., January 1, 2007; 37(4): 315 - 322. [Abstract] [Full Text] [PDF]
|
|